482 related items for PubMed ID: 25257673
1. Elevated D-dimer level is a risk factor for coronary artery lesions accompanying intravenous immunoglobulin-unresponsive Kawasaki disease.
Masuzawa Y, Mori M, Hara T, Inaba A, Oba MS, Yokota S.
Ther Apher Dial; 2015 Apr; 19(2):171-7. PubMed ID: 25257673
[Abstract] [Full Text] [Related]
2. Biomarkers of intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.
Kong WX, Ma FY, Fu SL, Wang W, Xie CH, Zhang YY, Gong FQ.
World J Pediatr; 2019 Apr; 15(2):168-175. PubMed ID: 30809758
[Abstract] [Full Text] [Related]
3. Persistent endothelial damage after intravenous immunoglobulin therapy in Kawasaki disease.
Sakurai Y, Takatsuka H, Onaka M, Takada M, Nishino M.
Int Arch Allergy Immunol; 2014 Apr; 165(2):111-8. PubMed ID: 25401215
[Abstract] [Full Text] [Related]
4. [Expression of sICAM-1 in children with intravenous immunoglobulin-resistant Kawasaki disease].
Liu F, Ding Y, Yin W.
Zhongguo Dang Dai Er Ke Za Zhi; 2013 Dec; 15(12):1109-12. PubMed ID: 24342209
[Abstract] [Full Text] [Related]
5. [Risk factors for coronary artery lesions in children with Kawasaki disease].
Li Y, Wang XM, Liu YL, Shi K, Yang YF, Guo YH.
Zhongguo Dang Dai Er Ke Za Zhi; 2012 Dec; 14(12):938-41. PubMed ID: 23234782
[Abstract] [Full Text] [Related]
6. [Clinical value of serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 for the prediction and early diagnosis of coronary artery lesion in patients with Kawasaki disease].
Peng Q, Zhou TF, Chen CH, Hua YM, Liu HM, Hong H, Zhang LY, Wu Q.
Zhonghua Er Ke Za Zhi; 2005 Sep; 43(9):676-80. PubMed ID: 16191301
[Abstract] [Full Text] [Related]
7. Kawasaki disease in Turkish children: a single center experience with emphasis on intravenous immunoglobulin resistance and giant coronary aneurysms.
Yılmazer MM, Özdemir R, Meşe T, Küçük M, Öner T, Devrim İ, Bayram N, Güven B, Tavlı V.
Turk J Pediatr; 2019 Sep; 61(5):648-656. PubMed ID: 32104995
[Abstract] [Full Text] [Related]
8. A Multicenter Study of Intravenous Immunoglobulin Non-response in Kawasaki Disease.
Wei M, Huang M, Chen S, Huang G, Huang M, Qiu D, Guo Z, Jiang J, Zhou X, Yu Q, Guo Y, Fu L, Gao W, Li F.
Pediatr Cardiol; 2015 Aug; 36(6):1166-72. PubMed ID: 25812827
[Abstract] [Full Text] [Related]
9. Association of lower eosinophil-related T helper 2 (Th2) cytokines with coronary artery lesions in Kawasaki disease.
Kuo HC, Wang CL, Liang CD, Yu HR, Huang CF, Wang L, Hwang KP, Yang KD.
Pediatr Allergy Immunol; 2009 May; 20(3):266-72. PubMed ID: 19438983
[Abstract] [Full Text] [Related]
10. N-terminal pro-brain natriuretic peptide and risk of coronary artery lesions and resistance to intravenous immunoglobulin in Kawasaki disease.
Yoshimura K, Kimata T, Mine K, Uchiyama T, Tsuji S, Kaneko K.
J Pediatr; 2013 Jun; 162(6):1205-9. PubMed ID: 23290510
[Abstract] [Full Text] [Related]
11. The effect of FcγRIIA and FcγRIIB on coronary artery lesion formation and intravenous immunoglobulin treatment responses in children with Kawasaki disease.
Chang LS, Lo MH, Li SC, Yang MY, Hsieh KS, Kuo HC.
Oncotarget; 2017 Jan 10; 8(2):2044-2052. PubMed ID: 27893416
[Abstract] [Full Text] [Related]
12. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.
Qiu H, He Y, Rong X, Ren Y, Pan L, Chu M, Wu R, Shi H.
Postgrad Med; 2018 May 10; 130(4):442-447. PubMed ID: 29745742
[Abstract] [Full Text] [Related]
13. Efficacy and limitation of infliximab treatment for children with Kawasaki disease intractable to intravenous immunoglobulin therapy: report of an open-label case series.
Mori M, Imagawa T, Hara R, Kikuchi M, Hara T, Nozawa T, Miyamae T, Yokota S.
J Rheumatol; 2012 Apr 10; 39(4):864-7. PubMed ID: 22337241
[Abstract] [Full Text] [Related]
14. [Clinical analysis of 942 cases of Kawasaki disease].
Zhang W, Li Q, Zhao XD, Tang XM, Wang XG, Wang M, Wu DQ, Ou Q, Yang XQ.
Zhonghua Er Ke Za Zhi; 2006 May 10; 44(5):324-8. PubMed ID: 16780705
[Abstract] [Full Text] [Related]
15. Difference in Risk Factors for Subtypes of Acute Cardiac Lesions Resulting from Kawasaki Disease.
Yamashita M, Ae R, Yashiro M, Aoyama Y, Sano T, Makino N, Nakamura Y.
Pediatr Cardiol; 2017 Feb 10; 38(2):375-380. PubMed ID: 27878631
[Abstract] [Full Text] [Related]
16. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease.
Tse SM, Silverman ED, McCrindle BW, Yeung RS.
J Pediatr; 2002 Apr 10; 140(4):450-5. PubMed ID: 12006960
[Abstract] [Full Text] [Related]
17. A low-frequency IL4R locus variant in Japanese patients with intravenous immunoglobulin therapy-unresponsive Kawasaki disease.
Amano Y, Akazawa Y, Yasuda J, Yoshino K, Kojima K, Kobayashi N, Matsuzaki S, Nagasaki M, Kawai Y, Minegishi N, Ishida N, Motoki N, Hachiya A, Nakazawa Y, Yamamoto M, Koike K, Takeshita T.
Pediatr Rheumatol Online J; 2019 Jul 03; 17(1):34. PubMed ID: 31269967
[Abstract] [Full Text] [Related]
18. Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease.
Furukawa T, Kishiro M, Akimoto K, Nagata S, Shimizu T, Yamashiro Y.
Arch Dis Child; 2008 Feb 03; 93(2):142-6. PubMed ID: 17962370
[Abstract] [Full Text] [Related]
19. Predictors for Intravenous Immunoglobulin Resistance in Patients with Kawasaki Disease.
Li W, Zhang L, Wang Z, He X, Lin H, Wang Y, Yuan J, Xie X, Zhang X, Qin Y, Huang P.
Int J Clin Pract; 2022 Feb 03; 2022():2726686. PubMed ID: 35989868
[Abstract] [Full Text] [Related]
20. TNF-α is superior to conventional inflammatory mediators in forecasting IVIG nonresponse and coronary arteritis in Chinese children with Kawasaki disease.
Hu P, Jiang GM, Wu Y, Huang BY, Liu SY, Zhang DD, Xu Y, Wu YF, Xia X, Wei W, Hu B.
Clin Chim Acta; 2017 Aug 03; 471():76-80. PubMed ID: 28526535
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
